Indefinite Delivery Contract 75N93020D00006
Award Date 4/1/20
Last Date to Order 3/31/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to Bioqual, Inc. with a ceiling value of $146.3 million and an award date of July 15, 2024. The contract runs through July 14, 2031. The IDIQ procures preclinical animal models and related services for evaluating countermeasures against infectious diseases. The contract covers four primary task areas: small animal models, non-human primate models, animal replacement models, and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a multiple-award indefinite-delivery contract to Bioqual, Inc. with a ceiling of $545.5 million on September 1, 2021. The contract runs through August 31, 2028. The originating solicitation (posted June 2020, due July 2020) was partially set aside for small businesses and sought a broad range of research support services including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
- This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Bioqual, Inc., a for-profit biomedical research services company located in Rockville, Maryland. The $136.6 million single-award IDC has an ultimate completion date of September 29, 2035 and will provide evaluation and testing services (ETS) for vaccines and other biologics for infectious diseases. Bioqual,...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded an indefinite-delivery contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $364,553,934 on December 1, 2021, as one of multiple awards under the Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents program. No set-aside applies to this vehicle. Place of performance is Rockville, Maryland. The IDIQ supports NIAID's development of preclinical and translational capabilities for...
- The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite delivery contract to American Foundation For Biological Research (doing business as Biomedical Research Institute) on July 15, 2024, with a ceiling value of $146.3 million and an ultimate completion date of July 14, 2031. The contract covers development and employment of animal and animal replacement models for infectious disease research, including small animal models, non-human primate models, and...
- The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery, multiple-award contract to The Administrators of Tulane Educational Fund, doing business as Tulane University, on April 1, 2020, with a ceiling of $66,355,351 and an ultimate completion date of March 31, 2027, for the Simian Vaccine Evaluation Units program supporting preclinical evaluation of HIV/AIDS vaccines and prevention strategies. Work is performed in New Orleans, Louisiana at Tulane's National...
- The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to PPD Development LP on September 1, 2021, with a ceiling of $545.5 million for comprehensive and rapid response capabilities supporting NIAID research programs through August 31, 2028. The originating solicitation, posted in June 2020, sought a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical...
- The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Sri International on April 15, 2023, with a ceiling of $98,878,757 and an ultimate completion date of April 14, 2030. This is a multiple-award vehicle with no set-aside restriction. Place of performance is Menlo Park, California. The IDIQ was established to procure preclinical development support services for HIV, pediatric, and prevention products, including preclinical gap filling, animal model...
- The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite delivery contract to Advanced Bioscience Laboratories, Inc. on June 8, 2017, with a ceiling of $318.5 million for preclinical development support services. The contract ultimately completed on June 9, 2024. Work was performed in Rockville, Maryland. The IDIQ supported NIAID's preclinical development initiatives spanning cGMP manufacturing of vaccines and biologics, process development, analytical testing,...
- The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Battelle Memorial Institute on July 15, 2024, with a ceiling of $146.3 million and an ultimate completion date of July 14, 2031. This is a single-award contract with no set-aside. Work is performed in Columbus, Ohio. The contract supports preclinical drug candidate evaluation, animal model development, and infectious disease research, including evaluation of antiviral drug candidates against mpox...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75N93020D00006-75N93023F00001 | Bioqual, Inc. | $2.0m | 9/1/23 | 8/31/25 | 9/19/24 | |
Delivery Order 75N93020D00006-75N93021F00001 | Bioqual, Inc. | $1.9m | 9/8/21 | 12/31/25 | 11/26/25 | |
Delivery Order 75N93020D00006-75N93022F00001 | Bioqual, Inc. | $1.2m | 5/16/22 | 4/30/25 | 1/8/25 | |
Delivery Order 75N93020D00006-75N93020F00001 | Bioqual, Inc. | $2.6m | 4/1/20 | 3/31/27 | 8/31/26 | |
Delivery Order 75N93020D00006-75N93020F00002 | Bioqual, Inc. | $1.4m | 4/1/20 | 3/31/27 | 8/31/26 |